+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Long-acting Contraception Market - Global Forecast 2026-2032- Product Image
Long-acting Contraception Market - Global Forecast 2026-2032- Product Image
New

Long-acting Contraception Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 180 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5715566
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The long-acting contraception market is experiencing a period of significant transformation, driven by advances in clinical technology, policy evolution, and changing organizational priorities. Decision-makers are navigating a dynamic landscape where product refinement and strategic partnerships increasingly define access and operational success.

Market Snapshot: Long-Acting Contraception Market Outlook

The Long-acting Contraception Market grew from USD 3.94 billion in 2025 to USD 4.21 billion in 2026 and is projected to expand at a CAGR of 7.21%, reaching USD 6.41 billion by 2032. This growth is underpinned by persistent clinical innovation, evolving patient and provider preferences, and increased emphasis on integrating long-acting methods into broader reproductive health frameworks across global regions.

Scope & Segmentation

  • Product Types: Includes implants (single-rod, multi-rod), injectable forms (intramuscular, subcutaneous), and intrauterine devices (copper, hormonal). Each subtype features unique administration protocols, influencing provider training and patient selection.
  • Care Settings: Encompasses family planning and specialty clinics, as well as public and private hospitals. Clinics provide focused, high-volume services, while hospitals manage diverse complexity and serve as key referral hubs.
  • Distribution Channels: Covers hospital pharmacies, retail pharmacies (chain and independent), and online platforms. These routes enable tailored patient access, provider engagement, and point-of-care coordination.
  • Regional Coverage: Americas (integration into primary care, equity outreach), Europe/Middle East/Africa (varied regulatory processes, scalable distribution), and Asia-Pacific (mature clinical centers, emerging decentralized models). Each region’s policy, culture, and infrastructure drive distinct adoption trajectories.
  • Technology Platforms: Incorporates innovative implant designs, next-generation injectables, and advanced intrauterine systems that reduce side effects, enhance user experience, and facilitate longer duration of use.

Key Takeaways

  • Technological refinements in device and formulation design are enhancing usability, supporting broader adoption beyond specialty clinics.
  • Care delivery models are evolving, with expanded roles for mid-level providers and growth in telehealth counseling, resulting in reduced access barriers.
  • Policy initiatives are reshaping procurement, reimbursement, and patient education, emphasizing autonomy and integration within routine health services.
  • Supply chain strategies have shifted in response to tariff adjustments and geopolitical uncertainties, prompting diversification of sourcing and investment in inventory transparency.
  • Strategic partnerships among manufacturers, distributors, and clinical networks accelerate evidence generation and dissemination of best practices.
  • Competitive advantage now relies equally on product innovation, operational excellence, and collaborative provider support.

Tariff Impact on Supply Chain and Access

The 2025 adjustments to United States tariffs generated substantial operational impacts across the long-acting contraception supply chain. Manufacturers reevaluated global sourcing, diversified supplier networks, and boosted local production capabilities. In response, health systems placed increased importance on procurement agility and inventory resilience. These developments have reinforced the necessity for geographic manufacturing flexibility and multilayered risk management as ongoing components of market strategy.

Methodology & Data Sources

This report applies a mixed-methods approach, incorporating expert interviews with clinicians, procurement specialists, and product managers, as well as review of peer-reviewed literature, regulatory documentation, and policy analysis. Qualitative synthesis and comparative analysis were used to validate observations and support actionable recommendations. Rigorous documentation and internal peer review ensured the robustness and relevance of insights for stakeholders.

Why This Report Matters

  • Offers decision-makers a comprehensive yet practical synthesis of trends and operational realities across clinical, commercial, and policy domains.
  • Enables cross-functional planning by linking segmentation analysis to actionable commercialization, procurement, and partnership strategies.
  • Supports alignment of organizational goals with emerging regulatory, technological, and equity-focused imperatives, guiding evidence-based growth and investment decisions.

Conclusion

Product innovation, operational readiness, and equity-driven strategies are converging to redefine the long-acting contraception market. Forward-thinking organizations that align these priorities will be best positioned to expand access and achieve sustainable impact in an evolving reproductive health landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Long-acting Contraception Market, by Product Type
8.1. Implant
8.1.1. Multi-Rod Implant
8.1.2. Single-Rod Implant
8.2. Injectable
8.2.1. Intramuscular Injectable
8.2.2. Subcutaneous Injectable
8.3. Intrauterine Device
8.3.1. Copper IUD
8.3.2. Hormonal IUD
9. Long-acting Contraception Market, by Duration Of Action
9.1. Short-term LAC (1-3 months)
9.2. Medium-term LAC (3-6 months)
9.3. Long-term LAC (1-5 years)
10. Long-acting Contraception Market, by End User
10.1. Clinics
10.1.1. Family Planning Clinic
10.1.2. Specialty Clinic
10.2. Hospitals
10.2.1. Private Hospital
10.2.2. Public Hospital
11. Long-acting Contraception Market, by Distribution Channel
11.1. Hospital Pharmacy
11.2. Online
11.2.1. Company Website
11.2.2. Third-Party Platform
11.3. Retail Pharmacy
11.3.1. Chain Pharmacy
11.3.2. Independent Pharmacy
12. Long-acting Contraception Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Long-acting Contraception Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Long-acting Contraception Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Long-acting Contraception Market
16. China Long-acting Contraception Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. AbbVie Inc.
17.6. Afaxys, Inc.
17.7. Agile Therapeutics, Inc.
17.8. Bayer AG
17.9. Cipla Limited
17.10. CooperCompanies, Inc.
17.11. Gedeon Richter Plc
17.12. HLL Lifecare Ltd.
17.13. Incepta Pharmaceuticals Ltd.
17.14. Lupin Limited
17.15. Mayne Pharma Group Limited
17.16. Merck & Co., Inc.
17.17. Organon & Co.
17.18. Pfizer Inc.
17.19. Pregna International Ltd.
17.20. Shanghai Dahua Pharmaceutical Co., Ltd.
17.21. SMB Corporation Pvt. Ltd.
17.22. Sun Pharmaceutical Industries Ltd
17.23. Teva Pharmaceutical Industries Ltd
17.24. Theramex Ltd.
17.25. Viatris Inc
List of Figures
FIGURE 1. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL LONG-ACTING CONTRACEPTION MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL LONG-ACTING CONTRACEPTION MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY DURATION OF ACTION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY IMPLANT, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY IMPLANT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY IMPLANT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY IMPLANT, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY MULTI-ROD IMPLANT, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY MULTI-ROD IMPLANT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY MULTI-ROD IMPLANT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY SINGLE-ROD IMPLANT, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY SINGLE-ROD IMPLANT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY SINGLE-ROD IMPLANT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY INJECTABLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY INTRAMUSCULAR INJECTABLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY INTRAMUSCULAR INJECTABLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY INTRAMUSCULAR INJECTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY SUBCUTANEOUS INJECTABLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY SUBCUTANEOUS INJECTABLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY SUBCUTANEOUS INJECTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY INTRAUTERINE DEVICE, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY INTRAUTERINE DEVICE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY INTRAUTERINE DEVICE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY INTRAUTERINE DEVICE, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY COPPER IUD, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY COPPER IUD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY COPPER IUD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY HORMONAL IUD, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY HORMONAL IUD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY HORMONAL IUD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY DURATION OF ACTION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY SHORT-TERM LAC (1-3 MONTHS), BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY SHORT-TERM LAC (1-3 MONTHS), BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY SHORT-TERM LAC (1-3 MONTHS), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY MEDIUM-TERM LAC (3-6 MONTHS), BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY MEDIUM-TERM LAC (3-6 MONTHS), BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY MEDIUM-TERM LAC (3-6 MONTHS), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY LONG-TERM LAC (1-5 YEARS), BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY LONG-TERM LAC (1-5 YEARS), BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY LONG-TERM LAC (1-5 YEARS), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY FAMILY PLANNING CLINIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY FAMILY PLANNING CLINIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY FAMILY PLANNING CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY SPECIALTY CLINIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY SPECIALTY CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRIVATE HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRIVATE HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY PUBLIC HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY PUBLIC HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY COMPANY WEBSITE, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY COMPANY WEBSITE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY COMPANY WEBSITE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY THIRD-PARTY PLATFORM, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY THIRD-PARTY PLATFORM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY THIRD-PARTY PLATFORM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY CHAIN PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY CHAIN PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY INDEPENDENT PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY INDEPENDENT PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. AMERICAS LONG-ACTING CONTRACEPTION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 90. AMERICAS LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 91. AMERICAS LONG-ACTING CONTRACEPTION MARKET SIZE, BY IMPLANT, 2018-2032 (USD MILLION)
TABLE 92. AMERICAS LONG-ACTING CONTRACEPTION MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 93. AMERICAS LONG-ACTING CONTRACEPTION MARKET SIZE, BY INTRAUTERINE DEVICE, 2018-2032 (USD MILLION)
TABLE 94. AMERICAS LONG-ACTING CONTRACEPTION MARKET SIZE, BY DURATION OF ACTION, 2018-2032 (USD MILLION)
TABLE 95. AMERICAS LONG-ACTING CONTRACEPTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 96. AMERICAS LONG-ACTING CONTRACEPTION MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 97. AMERICAS LONG-ACTING CONTRACEPTION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 98. AMERICAS LONG-ACTING CONTRACEPTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 99. AMERICAS LONG-ACTING CONTRACEPTION MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 100. AMERICAS LONG-ACTING CONTRACEPTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 101. NORTH AMERICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. NORTH AMERICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 103. NORTH AMERICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY IMPLANT, 2018-2032 (USD MILLION)
TABLE 104. NORTH AMERICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 105. NORTH AMERICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY INTRAUTERINE DEVICE, 2018-2032 (USD MILLION)
TABLE 106. NORTH AMERICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY DURATION OF ACTION, 2018-2032 (USD MILLION)
TABLE 107. NORTH AMERICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 108. NORTH AMERICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 109. NORTH AMERICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 110. NORTH AMERICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 111. NORTH AMERICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 112. NORTH AMERICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 113. LATIN AMERICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. LATIN AMERICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 115. LATIN AMERICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY IMPLANT, 2018-2032 (USD MILLION)
TABLE 116. LATIN AMERICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 117. LATIN AMERICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY INTRAUTERINE DEVICE, 2018-2032 (USD MILLION)
TABLE 118. LATIN AMERICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY DURATION OF ACTION, 2018-2032 (USD MILLION)
TABLE 119. LATIN AMERICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 120. LATIN AMERICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 121. LATIN AMERICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 122. LATIN AMERICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 123. LATIN AMERICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 124. LATIN AMERICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY IMPLANT, 2018-2032 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY INTRAUTERINE DEVICE, 2018-2032 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY DURATION OF ACTION, 2018-2032 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 137. EUROPE LONG-ACTING CONTRACEPTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 138. EUROPE LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 139. EUROPE LONG-ACTING CONTRACEPTION MARKET SIZE, BY IMPLANT, 2018-2032 (USD MILLION)
TABLE 140. EUROPE LONG-ACTING CONTRACEPTION MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 141. EUROPE LONG-ACTING CONTRACEPTION MARKET SIZE, BY INTRAUTERINE DEVICE, 2018-2032 (USD MILLION)
TABLE 142. EUROPE LONG-ACTING CONTRACEPTION MARKET SIZE, BY DURATION OF ACTION, 2018-2032 (USD MILLION)
TABLE 143. EUROPE LONG-ACTING CONTRACEPTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 144. EUROPE LONG-ACTING CONTRACEPTION MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 145. EUROPE LONG-ACTING CONTRACEPTION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 146. EUROPE LONG-ACTING CONTRACEPTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 147. EUROPE LONG-ACTING CONTRACEPTION MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 148. EUROPE LONG-ACTING CONTRACEPTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 149. MIDDLE EAST LONG-ACTING CONTRACEPTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 150. MIDDLE EAST LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 151. MIDDLE EAST LONG-ACTING CONTRACEPTION MARKET SIZE, BY IMPLANT, 2018-2032 (USD MILLION)
TABLE 152. MIDDLE EAST LONG-ACTING CONTRACEPTION MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 153. MIDDLE EAST LONG-ACTING CONTRACEPTION MARKET SIZE, BY INTRAUTERINE DEVICE, 2018-2032 (USD MILLION)
TABLE 154. MIDDLE EAST LONG-ACTING CONTRACEPTION MARKET SIZE, BY DURATION OF ACTION, 2018-2032 (USD MILLION)
TABLE 155. MIDDLE EAST LONG-ACTING CONTRACEPTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 156. MIDDLE EAST LONG-ACTING CONTRACEPTION MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 157. MIDDLE EAST LONG-ACTING CONTRACEPTION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 158. MIDDLE EAST LONG-ACTING CONTRACEPTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 159. MIDDLE EAST LONG-ACTING CONTRACEPTION MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 160. MIDDLE EAST LONG-ACTING CONTRACEPTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 161. AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 162. AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 163. AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY IMPLANT, 2018-2032 (USD MILLION)
TABLE 164. AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 165. AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY INTRAUTERINE DEVICE, 2018-2032 (USD MILLION)
TABLE 166. AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY DURATION OF ACTION, 2018-2032 (USD MILLION)
TABLE 167. AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 168. AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 169. AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 170. AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 171. AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 172. AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 173. ASIA-PACIFIC LONG-ACTING CONTRACEPTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 174. ASIA-PACIFIC LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 175. ASIA-PACIFIC LONG-ACTING CONTRACEPTION MARKET SIZE, BY IMPLANT, 2018-2032 (USD MILLION)
TABLE 176. ASIA-PACIFIC LONG-ACTING CONTRACEPTION MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 177. ASIA-PACIFIC LONG-ACTING CONTRACEPTION MARKET SIZE, BY INTRAUTERINE DEVICE, 2018-2032 (USD MILLION)
TABLE 178. ASIA-PACIFIC LONG-ACTING CONTRACEPTION MARKET SIZE, BY DURATION OF ACTION, 2018-2032 (USD MILLION)
TABLE 179. ASIA-PACIFIC LONG-ACTING CONTRACEPTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 180. ASIA-PACIFIC LONG-ACTING CONTRACEPTION MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 181. ASIA-PACIFIC LONG-ACTING CONTRACEPTION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 182. ASIA-PACIFIC LONG-ACTING CONTRACEPTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 183. ASIA-PACIFIC LONG-ACTING CONTRACEPTION MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 184. ASIA-PACIFIC LONG-ACTING CONTRACEPTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 185. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 186. ASEAN LONG-ACTING CONTRACEPTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 187. ASEAN LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 188. ASEAN LONG-ACTING CONTRACEPTION MARKET SIZE, BY IMPLANT, 2018-2032 (USD MILLION)
TABLE 189. ASEAN LONG-ACTING CONTRACEPTION MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 190. ASEAN LONG-ACTING CONTRACEPTION MARKET SIZE, BY INTRAUTERINE DEVICE, 2018-2032 (USD MILLION)
TABLE 191. ASEAN LONG-ACTING CONTRACEPTION MARKET SIZE, BY DURATION OF ACTION, 2018-2032 (USD MILLION)
TABLE 192. ASEAN LONG-ACTING CONTRACEPTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 193. ASEAN LONG-ACTING CONTRACEPTION MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 194. ASEAN LONG-ACTING CONTRACEPTION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 195. ASEAN LONG-ACTING CONTRACEPTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 196. ASEAN LONG-ACTING CONTRACEPTION MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 197. ASEAN LONG-ACTING CONTRACEPTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 198. GCC LONG-ACTING CONTRACEPTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 199. GCC LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 200. GCC LONG-ACTING CONTRACEPTION MARKET SIZE, BY IMPLANT, 2018-2032 (USD MILLION)
TABLE 201. GCC LONG-ACTING CONTRACEPTION MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 202. GCC LONG-ACTING CONTRACEPTION MARKET SIZE, BY INTRAUTERINE DEVICE, 2018-2032 (USD MILLION)
TABLE 203. GCC LONG-ACTING CONTRACEPTION MARKET SIZE, BY DURATION OF ACTION, 2018-2032 (USD MILLION)
TABLE 204. GCC LONG-ACTING CONTRACEPTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 205. GCC LONG-ACTING CONTRACEPTION MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 206. GCC LONG-ACTING CONTRACEPTION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 207. GCC LONG-ACTING CONTRACEPTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 208. GCC LONG-ACTING CONTRACEPTION MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 209. GCC LONG-ACTING CONTRACEPTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 210. EUROPEAN UNION LONG-ACTING CONTRACEPTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 211. EUROPEAN UNION LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 212. EUROPEAN UNION LONG-ACTING CONTRACEPTION MARKET SIZE, BY IMPLANT, 2018-2032 (USD MILLION)
TABLE 213. EUROPEAN UNION LONG-ACTING CONTRACEPTION MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 214. EUROPEAN UNION LONG-ACTING CONTRACEPTION MARKET SIZE, BY INTRAUTERINE DEVICE, 2018-2032 (USD MILLION)
TABLE 215. EUROPEAN UNION LONG-ACTING CONTRACEPTION MARKET SIZE, BY DURATION OF ACTION, 2018-2032 (USD MILLION)
TABLE 216. EUROPEAN UNION LONG-ACTING CONTRACEPTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 217. EUROPEAN UNION LONG-ACTING CONTRACEPTION MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 218. EUROPEAN UNION LONG-ACTING CONTRACEPTION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 219. EUROPEAN UNION LONG-ACTING CONTRACEPTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 220. EUROPEAN UNION LONG-ACTING CONTRACEPTION MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 221. EUROPEAN UNION LONG-ACTING CONTRACEPTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 222. BRICS LONG-ACTING CONTRACEPTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 223. BRICS LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 224. BRICS LONG-ACTING CONTRACEPTION MARKET SIZE, BY IMPLANT, 2018-2032 (USD MILLION)
TABLE 225. BRICS LONG-ACTING CONTRACEPTION MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 226. BRICS LONG-ACTING CONTRACEPTION MARKET SIZE, BY INTRAUTERINE DEVICE, 2018-2032 (USD MILLION)
TABLE 227. BRICS LONG-ACTING CONTRACEPTION MARKET SIZE, BY DURATION OF ACTION, 2018-2032 (USD MILLION)
TABLE 228. BRICS LONG-ACTING CONTRACEPTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 229. BRICS LONG-ACTING CONTRACEPTION MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 230. BRICS LONG-ACTING CONTRACEPTION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 231. BRICS LONG-ACTING CONTRACEPTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 232. BRICS LONG-ACTING CONTRACEPTION MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 233. BRICS LONG-ACTING CONTRACEPTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 234. G7 LONG-ACTING CONTRACEPTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 235. G7 LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 236. G7 LONG-ACTING CONTRACEPTION MARKET SIZE, BY IMPLANT, 2018-2032 (USD MILLION)
TABLE 237. G7 LONG-ACTING CONTRACEPTION MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 238. G7 LONG-ACTING CONTRACEPTION MARKET SIZE, BY INTRAUTERINE DEVICE, 2018-2032 (USD MILLION)
TABLE 239. G7 LONG-ACTING CONTRACEPTION MARKET SIZE, BY DURATION OF ACTION, 2018-2032 (USD MILLION)
TABLE 240. G7 LONG-ACTING CONTRACEPTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 241. G7 LONG-ACTING CONTRACEPTION MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 242. G7 LONG-ACTING CONTRACEPTION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 243. G7 LONG-ACTING CONTRACEPTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 244. G7 LONG-ACTING CONTRACEPTION MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 245. G7 LONG-ACTING CONTRACEPTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 246. NATO LONG-ACTING CONTRACEPTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 247. NATO LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 248. NATO LONG-ACTING CONTRACEPTION MARKET SIZE, BY IMPLANT, 2018-2032 (USD MILLION)
TABLE 249. NATO LONG-ACTING CONTRACEPTION MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 250. NATO LONG-ACTING CONTRACEPTION MARKET SIZE, BY INTRAUTERINE DEVICE, 2018-2032 (USD MILLION)
TABLE 251. NATO LONG-ACTING CONTRACEPTION MARKET SIZE, BY DURATION OF ACTION, 2018-2032 (USD MILLION)
TABLE 252. NATO LONG-ACTING CONTRACEPTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 253. NATO LONG-ACTING CONTRACEPTION MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 254. NATO LONG-ACTING CONTRACEPTION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 255. NATO LONG-ACTING CONTRACEPTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 256. NATO LONG-ACTING CONTRACEPTION MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 257. NATO LONG-ACTING CONTRACEPTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 258. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 259. UNITED STATES LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 260. UNITED STATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 261. UNITED STATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY IMPLANT, 2018-2032 (USD MILLION)
TABLE 262. UNITED STATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 263. UNITED STATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY INTRAUTERINE DEVICE, 2018-2032 (USD MILLION)
TABLE 264. UNITED STATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY DURATION OF ACTION, 2018-2032 (USD MILLION)
TABLE 265. UNITED STATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 266. UNITED STATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 267. UNITED STATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 268. UNITED STATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 269. UNITED STATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 270. UNITED STATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 271. CHINA LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 272. CHINA LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 273. CHINA LONG-ACTING CONTRACEPTION MARKET SIZE, BY IMPLANT, 2018-2032 (USD MILLION)
TABLE 274. CHINA LONG-ACTING CONTRACEPTION MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 275. CHINA LONG-ACTING CONTRACEPTION MARKET SIZE, BY INTRAUTERINE DEVICE, 2018-2032 (USD MILLION)
TABLE 276. CHINA LONG-ACTING CONTRACEPTION MARKET SIZE, BY DURATION OF ACTION, 2018-2032 (USD MILLION)
TABLE 277. CHINA LONG-ACTING CONTRACEPTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 278. CHINA LONG-ACTING CONTRACEPTION MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 279. CHINA LONG-ACTING CONTRACEPTION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 280. CHINA LONG-ACTING CONTRACEPTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 281. CHINA LONG-ACTING CONTRACEPTION MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 282. CHINA LONG-ACTING CONTRACEPTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Long-acting Contraception market report include:
  • AbbVie Inc.
  • Afaxys, Inc.
  • Agile Therapeutics, Inc.
  • Bayer AG
  • Cipla Limited
  • CooperCompanies, Inc.
  • Gedeon Richter Plc
  • HLL Lifecare Ltd.
  • Incepta Pharmaceuticals Ltd.
  • Lupin Limited
  • Mayne Pharma Group Limited
  • Merck & Co., Inc.
  • Organon & Co.
  • Pfizer Inc.
  • Pregna International Ltd.
  • Shanghai Dahua Pharmaceutical Co., Ltd.
  • SMB Corporation Pvt. Ltd.
  • Sun Pharmaceutical Industries Ltd
  • Teva Pharmaceutical Industries Ltd
  • Theramex Ltd.
  • Viatris Inc

Table Information

Report AttributeDetails
No. of Pages180
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 4.21 Billion
Forecasted Market Value ( USD ) by 2032 $ 6.41 Billion
Compound Annual Growth Rate7.2%
Regions CoveredGlobal
No. of Companies Mentioned22

Related Topics

Related Reports

Contraception Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Contraception Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 92 Pages
  • Global
From
Contraception Manufacturers - Industry Report - Product Image

Contraception Manufacturers - Industry Report

  • Report
  • 121 Pages
  • Global
From
Contraceptive Drugs and Devices Market Report 2025 - Product Image

Contraceptive Drugs and Devices Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Contraceptive Market - Global Forecast 2026-2032 - Product Image

Contraceptive Market - Global Forecast 2026-2032

  • Report
  • 185 Pages
  • Global
From
Contraceptive Devices Market Report 2025 - Product Image

Contraceptive Devices Market Report 2025

  • Report
  • 200 Pages
  • Global
From

About the Long Acting Contraception Market

The Long Acting Contraception market is a subset of the Personal Care Products industry. It includes a variety of products designed to provide long-term contraception, such as intrauterine devices (IUDs), contraceptive implants, and injectable contraceptives. These products are designed to provide a safe and effective form of contraception for women who wish to avoid pregnancy. Long Acting Contraception products are typically used by women who are looking for a more reliable form of contraception than traditional methods, such as the pill or condoms. They are also used by women who are looking for a more convenient form of contraception, as they do not require daily or weekly use. The Long Acting Contraception market is highly competitive, with a number of companies offering products. Some of the major players in the market include Bayer, Merck, Allergan, and Teva Pharmaceuticals. These companies offer a variety of products, ranging from IUDs to contraceptive implants and injectable contraceptives. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.